Convened with the Duke-Margolis Real-World Evidence Collaborative, this public convening will provide a venue to review recent RWE Collaborative activities, strategic real-world data and real-world evidence (RWD/E) policy developments, and promising future applications of RWD/E.
This year, speakers will focus on a few key topics:
- Barriers to accessing high-quality, reliable, and relevant real-world health data sufficient for regulatory decisions
- Applications of artificial intelligence in RWE studies
- Opportunities to use RWD/E to inform payment and coverage decisions for novel technologies
All are welcome to attend.